Sam Chen

Dr. Sam Chen

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2018 in ACS Nano
Verified
Journal Article
Closed access
JKJayesh A. Kulkarni
Jayesh A. Kulkarni
MDMaria M. Darjuan
Maria M. Darjuan
JMJoanne E. Mercer
Joanne E. Mercer
SCSam Chen
Sam Chen
RMRoy van der Meel
Roy van der Meel
PCPieter Cullis
Pieter Cullis

9 August 2019 in Accounts of Chemical Research
Verified
Journal Article
Closed access
JKJayesh A. Kulkarni
Jayesh A. Kulkarni
DWDominik Witzigmann
Dominik Witzigmann
SCSam Chen
Sam Chen
PCPieter Cullis
Pieter Cullis
RMRoy van der Meel
Roy van der Meel

1 September 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
SCSam Chen
Sam Chen
JZJosh Zaifman
Josh Zaifman
JKJayesh A. Kulkarni
Jayesh A. Kulkarni
IZIgor V. Zhigaltsev
Igor V. Zhigaltsev
YTYing K. Tam
Ying K. Tam
PCPieter R. Cullis
Pieter R. Cullis

7 February 2023 in Langmuir
Verified
Journal Article
Open access
ZJZygmunt J Jakubek
Zygmunt J Jakubek
SCSam Chen
Sam Chen
JZJosh Zaifman
Josh Zaifman
YTYuen Yi C. Tam
Yuen Yi C. Tam
SZShan Zou
Shan Zou
With recent advances and anticipated proliferation of lipid nanoparticle (LNP)-delivered vaccines and therapeutics, there is a need for the availability of internationally recognized reference materials of LNP systems. Accordingly, we developed six LNP and liposome (anionic, neutral, and cationic each) candidate reference material formulations and thoroughly characterized by dynamic light scattering their particle hydrodynamic size (Z-avr) and polydispersity. We also evaluated the particle size homogeneity and long-term -70 °C and 4 °C storage stability using multiple large sets of randomly selected vials for each formulation. The formulations stored at -70 °C remained stable and homogeneous for a minimum of 9 months. The Z-avr relative combined uncertainty and the long-term variability were both <1.3% for liposome formulations and anionic LNPs, (3.9% and 1.7%) for neutral LNPs, and (6.7% and 4.4%) for cationic LNPs. An inadvertent few-hour-long storage temperature increase to -35 °C due to a freezer malfunction resulted in a small change of the size and size distribution of anionic liposomes and LNPs but, unexpectedly, a larger size increase of the neutral and cationic liposomes (≤5%) and LNPs (≤25%). The mean Z-avr values of the LNPs stored at 4 °C appeared to slowly increase with t1/3, where t is the storage time, and the Z-avr between-vial heterogeneity and mean polydispersity index values appeared to decrease; no change was observed for liposomes. The size and size distribution evolution of LNPs stored at 4 °C was attributed to an incomplete equilibration of the formulations following the addition of sucrose prior to the initial freezing. Such a process of size increase and size distribution narrowing has not been previously discussed nor observed in the context of LNPs.

8 June 2021 in Langmuir
Verified
Journal Article
Closed access
JKJayesh A. Kulkarni
Jayesh A. Kulkarni
SCSam Chen
Sam Chen
YTYuen Yi C. Tam
Yuen Yi C. Tam

13 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Abdulaziz AlhussanAbdulaziz Alhussan
Abdulaziz Alhussan
NJNolan Jackson
Nolan Jackson
SESarah Eaton
Sarah Eaton
NSNancy Dos Santos
Nancy Dos Santos
IBIngrid Barta
Ingrid Barta
DCDevika Chithrani
Devika Chithrani
Current chemoradiation therapy suffers from normal tissue toxicity. Thus, we are proposing incorporating gold nanoparticles (GNPs) and docetaxel (DTX), as they have shown very promising synergetic radiosensitization effects. Here, we explored the effect of a DTX prodrug encapsulated in lipid nanoparticles (LNPDTX-P) on GNP uptake in pancreatic cancer models in vitro and in vivo. For the in vitro experiment, a pancreatic cancer cell line, MIA PaCa-2, was cultured and dosed with 1 nM GNPs and 45 nM free DTX or an equivalent dose of LNPDTX-P. For the in vivo experiment, MIA PaCa-2 cells were implanted subcutaneously in NRG mice, and the mice were dosed with 2 mg/kg of GNPs and 6 mg/kg of DTX or an equivalent dose of LNPDTX-P. The results show that LNPDTX-P-treated tumour samples had double the amount GNPs compared to control samples, both in vitro and in vivo. The results are very promising, as LNPDTX-P have superior targeting of tumour tissues compared to free DTX due to their nanosize and their ability to be functionalized. Because of their minimal toxicity to normal tissues, both GNPs and LNPDTX-P could be ideal radiosensitization candidates in radiotherapy and would produce very promising synergistic therapeutic outcomes.